All News

Mar. 10 Novavax, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 03:40 PM
Mar. 03 Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM
Feb. 26 Health Care Down Amid Mixed Earnings -- Health Care Roundup DJ
Feb. 26 Novavax raises revenue forecast on boost from vaccine deals, shares soar RE
Feb. 26 Novavax to Participate in Upcoming Investor Conferences PR
Feb. 26 Keros Therapeutics, Inc. Announces Board Changes, Effective March 9, 2026 CI
Feb. 26 Novavax outlook 2026 adjusted total revenue $230 mln - $270 mln RE
Feb. 26 Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals RE
Feb. 26 Novavax, Inc., Q4 2025 Earnings Call, Feb 26, 2026
Feb. 26 Top Midday Gainers MT
Feb. 26 Novavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
Feb. 26 Novavax Shares Jump After Swinging to Profit in Q4 MT
Feb. 26 Novavax raises revenue forecast on boost from vaccine deals, shares soar RE
Feb. 26 Earnings Flash (NVAX) Novavax Posts Q4 Total Revenue $147.1M, vs. FactSet Est of $89.8M MT
Feb. 26 Earnings Flash (NVAX) Novavax Posts Q4 EPS $0.11, vs. FactSet Est of $0.48 Loss MT
Feb. 26 Novavax: Q4 Earnings Snapshot AQ
Feb. 26 Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights PR
Feb. 19 Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 PR
Jan. 22 Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality RE
Jan. 20 Novavax Strikes License Deal With Pfizer for Use of Matrix-M Adjuvant DJ
Jan. 20 Novavax, Inc. Enters into A License and Option Agreement with Pfizer Inc CI
Jan. 20 Novavax Enters Non-Exclusive Licensing Deal With Pfizer MT
Jan. 20 Novavax Inc enters license agreement with Pfizer - SEC filing RE
Jan. 20 Novavax signs licensing agreement with Pfizer for vaccine development RE
Jan. 20 Novavax Announces Entering into a License Agreement with Pfizer PR
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW